Kimberly Chong

Array ( [id] => 5126416 [patent_doc_number] => 20070238687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'MODULATION OF GLUCAGON RECEPTOR EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/697262 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31562 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238687.pdf [firstpage_image] =>[orig_patent_app_number] => 11697262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126419 [patent_doc_number] => 20070238690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'MODULATION OF GLUCAGON RECEPTOR EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/697280 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31563 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238690.pdf [firstpage_image] =>[orig_patent_app_number] => 11697280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385201 [patent_doc_number] => 20090226446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Method to Inhibit the Propagation of an Undesired Cell Population' [patent_app_type] => utility [patent_app_number] => 12/226013 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13121 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226446.pdf [firstpage_image] =>[orig_patent_app_number] => 12226013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126417 [patent_doc_number] => 20070238688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'MODULATION OF GLUCAGON RECEPTOR EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/697270 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31563 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238688.pdf [firstpage_image] =>[orig_patent_app_number] => 11697270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4978128 [patent_doc_number] => 20070219362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'siRNA targeting azurocidin 1 (Cartionic Antimicrobial protein 37)' [patent_app_type] => utility [patent_app_number] => 11/732810 [patent_app_country] => US [patent_app_date] => 2007-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 34058 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219362.pdf [firstpage_image] =>[orig_patent_app_number] => 11732810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4530472 [patent_doc_number] => 07923548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-12 [patent_title] => 'Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1' [patent_app_type] => utility [patent_app_number] => 11/696015 [patent_app_country] => US [patent_app_date] => 2007-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9831 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/923/07923548.pdf [firstpage_image] =>[orig_patent_app_number] => 11696015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4492415 [patent_doc_number] => 07955848 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-07 [patent_title] => 'MicroRNA biomarkers for human breast and lung cancer' [patent_app_type] => utility [patent_app_number] => 11/730570 [patent_app_country] => US [patent_app_date] => 2007-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26853 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/955/07955848.pdf [firstpage_image] =>[orig_patent_app_number] => 11730570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126420 [patent_doc_number] => 20070238691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Inhibition of HIV replication and expression of p24 with eIF-5A' [patent_app_type] => utility [patent_app_number] => 11/727748 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8469 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238691.pdf [firstpage_image] =>[orig_patent_app_number] => 11727748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9607642 [patent_doc_number] => 08784806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Screening method' [patent_app_type] => utility [patent_app_number] => 12/294603 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 9191 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12294603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474441 [patent_doc_number] => 20090247607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION' [patent_app_type] => utility [patent_app_number] => 12/294388 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30798 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247607.pdf [firstpage_image] =>[orig_patent_app_number] => 12294388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4604605 [patent_doc_number] => 07985584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-26 [patent_title] => 'MicroRNA fingerprints during human megakaryocytopoiesis' [patent_app_type] => utility [patent_app_number] => 12/293471 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 25 [patent_no_of_words] => 26760 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/985/07985584.pdf [firstpage_image] =>[orig_patent_app_number] => 12293471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5086083 [patent_doc_number] => 20070276134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'COMPOSITIONS AND METHODS FOR COMPLEXES OF NUCLEIC ACIDS AND ORGANIC CATIONS' [patent_app_type] => utility [patent_app_number] => 11/676226 [patent_app_country] => US [patent_app_date] => 2007-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12789 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20070276134.pdf [firstpage_image] =>[orig_patent_app_number] => 11676226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9020451 [patent_doc_number] => 08530436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Methods and compositions for transdermal delivery of nucleotides' [patent_app_type] => utility [patent_app_number] => 11/699772 [patent_app_country] => US [patent_app_date] => 2007-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 4499 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11699772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652162 [patent_doc_number] => 20080039418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN' [patent_app_type] => utility [patent_app_number] => 11/627916 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22519 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039418.pdf [firstpage_image] =>[orig_patent_app_number] => 11627916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259660 [patent_doc_number] => 20070213292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/657341 [patent_app_country] => US [patent_app_date] => 2007-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 39814 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213292.pdf [firstpage_image] =>[orig_patent_app_number] => 11657341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4565699 [patent_doc_number] => 07846907 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene' [patent_app_type] => utility [patent_app_number] => 11/656349 [patent_app_country] => US [patent_app_date] => 2007-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8164 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846907.pdf [firstpage_image] =>[orig_patent_app_number] => 11656349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5159386 [patent_doc_number] => 20070172430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'DRY POWDER COMPOSITIONS FOR RNA INFLUENZA THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 11/623306 [patent_app_country] => US [patent_app_date] => 2007-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14811 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172430.pdf [firstpage_image] =>[orig_patent_app_number] => 11623306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7977973 [patent_doc_number] => 08071734 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Nucleic acid-based detection' [patent_app_type] => utility [patent_app_number] => 11/645362 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 35 [patent_no_of_words] => 15562 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071734.pdf [firstpage_image] =>[orig_patent_app_number] => 11645362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9704114 [patent_doc_number] => 08829178 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Immuno-RNA-constructs' [patent_app_type] => utility [patent_app_number] => 12/086817 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 13752 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12086817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321794 [patent_doc_number] => 20100113557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHOD FOR PREVENTION OF TUMOR' [patent_app_type] => utility [patent_app_number] => 12/097443 [patent_app_country] => US [patent_app_date] => 2006-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9786 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113557.pdf [firstpage_image] =>[orig_patent_app_number] => 12097443 [rel_patent_id] =>[rel_patent_doc_number] =>)